Investor Presentation • Oct 9, 2020
Investor Presentation
Open in ViewerOpens in native device viewer
Certain statements in this slide show, including those addressing the Company's beliefs, plans, objectives, estimates or expectations of possible future results or events, are forward-looking statements. Forward-lookingstatements involve known or unknown risks, including general economic and business conditions, and conditions in the industry we operate and may be affected should our assumptions turn out to be inaccurate. Consequently, no forward-looking statement can be guaranteed and actual future results, performance, or achievements may vary materially from those expressed or implied by such forward-looking statements. The Company undertakes no obligation about the contents nor to update the forward-looking statements to reflect events or circumstances that may arise after the date hereof.
Hi-Tech industrial group providing laser solutions with proprietary technologies and know how developed over 35 years
Listed on Milan's Stock Exchange Star segment since year 2000
More than 20 companies active worldwide on several laser application segments and markets
Progressively widening its worldwide presence achieving continuous growth over the years More than 50,000 laser sources sold and 5% of revenue invested in R&DMore than 125 patents
More than 115 R&D specialists
Source: Daniel Associates
Requirements for fast and minimally invasive surgical procedures
Daniel Associates:
Medical aesthetics market 2018 to 202310.23% CAGR
| 2 0 1 8 |
2 0 2 4 |
C a g r |
||
|---|---|---|---|---|
| l h d F i A i P t t t a c a e s e c s r o u c s |
8 3 1. 1 |
3. 6 3 8 |
0, % 1 7 |
|
| d C i i B D t o y o n o u r n g e v c e s |
1. 7 0 8 |
3. 1 7 2 |
% 1 0, 3 |
|
| l C i I t t o s m e c m p a n s |
1. 3 2 1 |
2. 4 1 5 |
1 0, 0 % |
|
| h d d l P i i i i i t s c a n- s p e n c e c o s m o c e u c a s |
||||
| d k i a n s n |
1. 1 0 4 |
1. 9 0 3 |
1 0, 2 % |
|
| k h S i i i A D t t n e s e c e v c e s |
9 3 8 |
1. 7 6 2 |
% 1 0, 2 |
|
| h d d l h i i i i P s c a n- s p e n c e e e a s y |
||||
| d t p r o u c s |
9 1 0 |
1. 5 5 1 |
1 0, 0 % |
|
| l d H i i a r r e m o v a e v c e s |
8 3 7 |
3 2 1. 4 |
0, 0 % 1 |
|
| l d i T t t a o o r e m o v a e v c e s |
8 7 |
1 5 3 |
% 9, 9 |
|
| h d l f d i T t t r e a p r o u c s |
7 3 |
1 2 5 |
9, 8 % |
|
| l l d N i i t t t a r e a m e n a s e r e v c e s |
6 1 |
1 1 0 |
9, 5 % |
Sou : Da nie l As iate rce soc s |
| 8. 8 1 6 |
1 6. 2 6 1 |
| 2 0 1 8 |
2 0 2 4 |
C a g r |
|
|---|---|---|---|
| h i N A t o r m e r c a |
3. 1 4 7 |
5. 6 8 9 |
9, 9 % |
| E r o p e u |
1. 9 5 8 |
3. 4 8 0 |
% 9, 4 |
| f i i i A P s a a c c |
2. 3 4 3 |
4. 6 3 5 |
% 1 1, 6 |
| d d l & f M i E A i t e a s r c a |
8 2 2 |
1. 4 9 2 |
% 9, 8 |
| L i A i t a n m e r c a |
5 4 7 |
9 6 5 |
9, 4 % |
| 8. 8 1 6 |
1 6. 2 6 1 |
||
Laser systems increasingly adopted in high quality manufacturing for uniqueness, flexibility, environment friendliness, productivity
"The global industrial lasers systems market size was valued at \$20,120.2 million in 2018, and is projected to reach \$36,510.6 million by 2026, growing at a CAGR of 7.5% from 2019 to 2026"
Unique high end system for cellulite, localized adiposities, fat removal, submental treatments
A family of unique combinations of superluminescent matrices with Tents and EMS
Discovery Pico DermDesigned for asian skins
PicoStarThe most powerful picosecondlaser in the marketplace
Chrome StationThree wavelengthsmulti platform
New FIBER DUST
One of two worldwide players in high power medical fiber lasers
Our novel disruptive technology for the most effective stones micro fragmentation
MiS (MLS Family) For degenerative neuropathies
10 kW Average power in 2020 sales bookings
30 kW systems to come in 2020
Laser cutting of technical tissue, or plastics for protection and social distancing
Up to 1,2 KW CO2 (RF)
| '0 E 0 0 u r o |
/ / 3 0 0 6 1 9 |
% | / / 3 0 0 6 2 0 |
% | % V a r. |
|---|---|---|---|---|---|
| d l M i e c a |
1 1 2 1 2 9 |
% 5 9 5 , |
1 0 0 3 0 9 |
% 6 1 7 , |
% 1 0 5 - , |
| d l I i t n s r a u |
7 6 3 2 1 |
4 0 5 % , |
6 2 2 1 2 |
3 8 3 % , |
1 8 5 % - , |
| l T R t o a e v e n u e s |
1 8 8 4 5 0 |
% 1 0 0 0 , |
1 6 2 5 2 1 |
% 1 0 0 0 , |
% 1 3 8 - , |
| G i r o s s m a r g n |
7 4 3 8 5 |
3 9 5 % , |
5 9 8 7 7 |
3 6 8 % , |
1 9 5 % - , |
| E B I T D A |
2 0 6 0 4 |
1 0 9 % , |
1 4 4 8 5 |
8 9 % , |
2 9 7 % - , |
| E B I T |
1 6 7 1 3 |
8 9 % , |
9 2 8 8 |
5 7 % , |
4 4 4 % - , |
| P I t r e a x n c o m e |
6 8 9 1 4 |
9 0 % , |
8 9 3 4 |
% 5 5 , |
% 4 7 1 - , |
| i N t e n c o m e |
0 2 2 3 1 |
% 5 4 , |
6 0 4 1 |
3 9 % , |
3 % 7 4 - , |
| h I N t e n c o m e p e r s a r e |
0 3 5 , |
0 3 3 , |
|||
| '0 E 0 0 r o u |
/ / 3 1 1 2 1 9 |
/ / 3 0 0 6 2 0 |
% V a r. |
|---|---|---|---|
| l T t t t o a n o n c u r r e n a s s e s |
1 1 0 9 6 6 |
1 1 2 9 3 5 |
1, % 5 |
| k l W i C i N t t e o r n g a p a |
1 1 0 6 2 7 |
1 2 8 9 3 6 |
1 6 % 5 , |
| / h b l b l O i S T t e r r e c e v a e s p a y a e s |
( ) 3 2 1 1 7 |
( ) 2 9 8 3 7 |
% 4 1 - , |
| f l i i i i N t t e n a n c a p o s o n |
6 1 4 1 9 |
2 7 9 2 8 |
% 5 4 5 - , |
| l b l i i i i L t t o n g e r m a e s |
2 9 1 1 7 |
6 2 1 4 1 |
3 % 4 5 , |
| i N E t t e q u y |
2 4 0 6 3 3 |
2 2 3 2 0 8 |
% 7 2 - , |
| l l d N i t t e c a p a e m p o e y |
1 7 9 2 1 4 |
1 9 5 2 7 9 |
% 9 0 , |
| k l l N W i C i t t e o r n g a p a o n s a e s |
2 7 6 % , |
3 9 7 % , |
|
| R O C E |
% 2 1, 3 |
% 9 5 , |
|
| / ( l l d ) E B I T N i t t e c a p a e m p o e y |
|||
| C a p e x |
2 3 4 7 1 |
5 0 8 9 |
|
| 2 9 |
| in m ln Am nts ou |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| h, Se 3 0 2 0 2 0 t. t p / d ica l he ic M Ae t t e s |
Pr ice |
Re ve nu e |
Va % r. Re v. |
E B I T |
E B I T % |
M K. Ca p. |
E V |
/ les E V Sa ( *) |
/ ( *) E V E B I T |
/ k P Bo o lue Va |
| Cu te ra |
\$ 1 6, 2 9 |
\$ 5 9 |
-3 0 % |
\$ ( ) 2 3 |
-3 9 % |
\$ 3 2 6 |
\$ 2 9 5 |
2, 5 |
n. a. |
6, 2 |
| de In M o |
\$ 3 2, 0 7 |
\$ 1 7 |
3 % |
\$ 1 4 |
2 0 % |
\$ 1. 1 2 0 |
\$ 9 1 7 |
6, 4 |
3 2, 5 |
5, 5 |
| Ve nu s |
\$ 2, 2 3 |
\$ 3 2 |
-4 0 % |
\$ ( ) 5 3 |
-1 6 8 % |
\$ 9 8 |
\$ 1 5 3 |
2, 4 |
n. a. |
2, 4 |
| l S isr d ica M am e |
\$ 0, 3 4 |
\$ 2 7 |
-1 6 % |
\$ 6 |
9 % |
\$ 1 8 4 |
\$ 8 5 |
0, 4 |
4, 5 |
0, 5 |
| ic Lu tro n |
€ 4, 1 6 |
€ 3 3 |
-1 8 % |
-€ 4 |
-1 2 % |
€ 1 0 8 |
€ 9 3 |
1, 4 |
n. a. |
1, 3 |
| du ia l In tr s |
||||||||||
| ho I P G P ics Co to n |
\$ 1 6 1, 0 0 |
\$ 5 4 6 |
-2 0 % |
\$ 9 2 |
1 7 % |
\$ 8. 5 7 0 |
\$ 7. 3 2 5 |
6, 7 |
3 9, 8 |
3, 5 |
| im du ie Pr In tr a s |
€ 2, 0 1 7 |
€ 8 1 5 |
-2 % 7 |
-€ 1 |
% -1 |
€ 3 3 1 |
€ 2 6 5 |
0, 8 |
n. a. |
0, 8 |
| 's Ha La n se r |
¥ 3 4, 0 5 |
¥ 5. 1 3 0 |
8 % |
¥ 4 8 7 |
9 % |
¥ 3 8. 4 4 0 |
¥ 3 9. 9 0 5 |
3, 9 |
4 1, 0 |
4, 0 |
| l. ( ) 1 E En |
€ 2 2, 0 7 |
€ 1 6 3 |
-1 4 % |
€ 9 |
6 % |
€ 4 4 5 |
€ 4 0 2 |
1, 4 |
2 4, 0 |
2, 0 |
(1) EV and multiplies as for previous slide
(*) Revenue,Ebit and earnings annualized
Enrico ROMAGNOLI Investor Relations Managertel. +39 055-8826807E-mail: [email protected]
Financial Communication, IR and Press Office Bianca FERSINI MASTELLONI [email protected] MARONGIU [email protected]. +39 06-69923324
Contacts
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.